The Use of Intralipid Infusions in the Prevention of Embryo Implantation Failure
- PMID: 38435143
- PMCID: PMC10907924
- DOI: 10.7759/cureus.53368
The Use of Intralipid Infusions in the Prevention of Embryo Implantation Failure
Abstract
Intralipids have been suggested to suppress uterine natural killer cell activity, which could potentially improve implantation rates in women with recurrent loss. We report a case of a 41-year-old African woman with recurrent pregnancy loss who had elevated uterine killer cell activity and for whom intralipid infusion was used to achieve pregnancy. We recommend routine uterine natural killer cell testing for women with recurrent pregnancy loss and further research on newer intravenous lipid emulsions in fertility medicine.
Keywords: immunomodulation; in vitro fertilization; intralipid; intravenous lipid emulsion; recurrent pregnancy loss; uterine natural killer cells.
Copyright © 2024, Anya et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
The effect of administration of intravenous intralipid on pregnancy outcomes in women with implantation failure after IVF/ICSI with non-donor oocytes: A randomised controlled trial.Eur J Obstet Gynecol Reprod Biol. 2019 Sep;240:45-51. doi: 10.1016/j.ejogrb.2019.06.007. Epub 2019 Jun 13. Eur J Obstet Gynecol Reprod Biol. 2019. PMID: 31228675 Clinical Trial.
-
Intravenous intralipid therapy is not beneficial in having a live delivery in women aged 40-42 years with a previous history of miscarriage or failure to conceive despite embryo transfer undergoing in vitro fertilization-embryo transfer.Clin Exp Obstet Gynecol. 2016;43(1):14-5. Clin Exp Obstet Gynecol. 2016. PMID: 27048011
-
Intralipid therapy and adverse reproductive outcome: is there any evidence?Reprod Fertil. 2021 Jun 3;2(3):173-186. doi: 10.1530/RAF-20-0052. eCollection 2021 Jul. Reprod Fertil. 2021. PMID: 35118388 Free PMC article.
-
Intralipid therapy for unexplained recurrent miscarriage and implantation failure: Case-series and literature review.Eur J Obstet Gynecol Reprod Biol. 2020 Sep;252:100-104. doi: 10.1016/j.ejogrb.2020.06.017. Epub 2020 Jun 16. Eur J Obstet Gynecol Reprod Biol. 2020. PMID: 32592916 Review.
-
Lipid emulsion therapy in women with recurrent pregnancy loss and repeated implantation failure: The role of abnormal natural killer cell activity.J Cell Mol Med. 2021 Mar;25(5):2290-2296. doi: 10.1111/jcmm.16257. Epub 2021 Feb 5. J Cell Mol Med. 2021. PMID: 33544456 Free PMC article. Review.
Cited by
-
Enhancing Endometrial Receptivity Assessment Outcomes in Recurrent Implantation Failure: Intralipid Infusion and Acupuncture as Complementary Therapies.J Pharm Bioallied Sci. 2025 May;17(Suppl 1):S1026-S1029. doi: 10.4103/jpbs.jpbs_171_25. Epub 2025 Apr 12. J Pharm Bioallied Sci. 2025. PMID: 40511046 Free PMC article.
References
-
- In memory of Arvid Wretlind 1919 - 2002. Isaksson B, Hambraeus L, Vinnars E, Samuelson G, Larsson J, Asp NG. Food Nutr Res. 191920022002;46:117.
-
- Computerized energy balance and complications in critically ill patients: an observational study. Dvir D, Cohen J, Singer P. Clin Nutr. 2006;25:37–44. - PubMed
-
- Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Weinberg GL, VadeBoncouer T, Ramaraju GA, Garcia-Amaro MF, Cwik MJ. Anesthesiology. 1998;88:1071–1075. - PubMed
Publication types
LinkOut - more resources
Full Text Sources